| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Prairie Health Ventures is a Lincoln, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Continuing Ed Courses is a Poway, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
PMSI is the nation's leading single-source provider of prescription medications, medical equipment and in-home medical services for the workers' compensation, chronically ill and catastrophically inju.
Ameritox is the nation's leader in pain prescription monitoring. Only Ameritox offers RxGuardian, the most thorough and personalized lab report available.